Search Results for ""

Oncology Nurse Psychoeducational Interventions Video

When it comes to oncologic emergencies, early identification and intervention achieve the best outcomes, but some emergencies are harder to recognize. “Oncology nurses are often the first to pick up on important symptoms of serious complications,” Laura Zitella, MS, RN, ACNP-BC, AOCN®, nurse practitioner at the University of California, San Francisco, said. Zitella joined Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to talk about recognizing less common complications seen in patients with cancer, such as adrenal crisis, pulmonary embolism, and malignant small bowel obstructions.

“Cultural competence is about being able to deliver care while respecting and valuing the differences people bring with them to the table. Did we consider their uniqueness? Have we done our best to care for them in a way that’s individualized?” Erica Fischer-Cartlidge, DNP, RN, AOCNS®, EBP-CH, chief clinical officer at ONS, told Jaime Weimer, MSN, RN, AGCNS-BC, AOCNS®, oncology clinical specialist at ONS, during a conversation about cultural considerations that can arise in cancer care and how oncology nurses can deliver culturally competent care.

“It’s incumbent on us as nurses to stay informed about these newly approved drugs or new indications in drugs because we’re the front line in helping these patients manage adverse events,” Teresa Knoop, MSN, RN, AOCN®, nurse consultant in Nashville, TN, told Jaime Weimer, MSN, RN, AGCNS-BC, AOCNS®, oncology clinical specialist at ONS, during a conversation about the latest updates and approvals in oncology pharmacology.

“It’s important for all nurses to advocate—for themselves, for their practice, for their profession, for their patients. Without the nursing community advocating for itself, no other entity will. It is the nurses’ responsibility to be their own advocate,” Alec Stone, MA, MPA, ONS Director of Government Affairs and Advocacy, told Jaime Weimer, MSN, RN, AGCNS-BC, AOCNS®, oncology clinical specialist at ONS, during a conversation about how you can advocate for oncology nursing with ONS.

“When we are able to connect with the things that give us meaning in our life, it makes us stronger, it makes us happier, it makes our life more fulfilled,” Caroline Peacock, ACPE certified educator, LCSW, Episcopal priest, and director of spiritual health and community care at the Winship Cancer Institute of Emory University in Atlanta, GA, said in a conversation with Jaime Weimer, MSN, RN, AGCNS-BC, AOCNS®, oncology clinical specialist at ONS. Peacock discussed how oncology nurses can support patients’ spirituality during cancer care.

What is it like to guide a professional association that serves more than 100,000 oncology nurses? ONS Directors-at-Large Deborah “Hutch” Allen, PhD, RN, CNS, FNP-BC, AOCNP®, Kris Mathey, MS, APRN-CNP, AOCNP®, and Jeanene “Gigi” Robison, MSN, APRN, AOCN®, reflect on how their varied nursing backgrounds and ONS experiences help the ONS Board to support a diverse membership during a conversation with ONS Executive Director Lori Brown. They also shared the professional and personal rewards that nurses can reap when getting involved with ONS at any level.

“Genomics is part and parcel of oncology treatment today. Even if a patient’s genomics might not affect the current choice of therapy, it may do so in the future. The use of genomics and biomarkers is just an evidence-based expansion and extension of our previous care,” ONS member Kristin Daly, MSN, ANP-BC, AOCNP®, nurse practitioner at the Washington University School of Medicine in St. Louis, MO, said in a conversation with Jaime Weimer, MSN, RN, AGCNS-BC, AOCNS®, oncology clinical specialist at ONS. Daly and Weimer discussed oncology nurses’ educational needs to bridge knowledge gaps in cancer genomics, identified genomics tools and resources specifically designed for clinical nursing practice, and shared strategies to implement them inn your patient care processes.

“These policies, procedures, order sets, and algorithms for oncologic emergencies are so important. They give you knowledge in your back pocket: This is the way we’re going to treat this, this is the way to quickly respond to this, and this is the way to treat this in the safest way possible,” ONS member Cassie Durand, MS, RN, CNS, AGCNS-BC, OCN®, clinical nurse specialist at Memorial Sloan-Kettering Cancer Center’s Long Island, NY, regional site, told Jaime Weimer, MSN, RN, AGCNS-BC, AOCNS®, oncology clinical specialist at ONS. Durand discussed how to develop and apply procedures to care for patients with oncologic emergencies.

“We found that nurses still needed clarity of terminology and the rationale for germline, somatic, and homologous recombination deficiency testing,” ONS member Paula Anastasia, MN, RN, AOCN®, clinical nurse specialist for UCLA Health in Los Angeles, CA, told Jaime Weimer, MSN, RN, AGCNS-BC, AOCNS®, oncology clinical specialist at ONS. Anastasia discussed the findings of a July 2022 ONS focus group that she facilitated on PARP inhibitor therapy, biomarker testing and terminology, and oral medication adherence for patients with ovarian cancer. This podcast episode is supported by a sponsorship from AstraZeneca. ONS is solely responsible for the criteria, objectives, content, quality, and scientific integrity of its programs and publications.